Bibliographic Details
| Title: |
Phase II randomized study of PM01183 versus topotecan in patients with platinum-resistant/refractory advanced ovarian cancer. |
| Authors: |
Poveda, A.1 apoveda@fivo.org, del Campo, J. M.2, Ray-Coquard, I.3, Alexandre, J.4, Provansal, M.5, Guerra Alía, E. M.6, Casado, A.7, Gonzalez-Martin, A.8, Fernández, C.9, Rodriguez, I.9, Soto, A.9, Kahatt, C.9, Fernández Teruel, C.9, Galmarini, C. M.9, Pérez de la Haza, A.9, Bohan, P.9, Berton-Rigaud, D.10 |
| Source: |
Annals of Oncology. Jun2017, Vol. 28 Issue 6, p1280-1287. 8p. 4 Charts, 1 Graph. |
| Database: |
Academic Search Ultimate |
